Back to the directory
Dorian Therapeutics
New therapeutics to rejuvenate tissue and treat age-related diseases
- Founded
- 2018
- Status
- Acquired
- Stage
- Early
- Team size
- 8
- Location
- San Francisco, CA, USA; San Carlos
- Category
- Biotech & Drug Discovery
- Sector
- Therapeutics
Anti-AgingBiotechTherapeutics
Federal research funding
5 NIH awards totalling $4,513,772, FY2021 to FY2024.
- Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis
- Epigenetic modulation of cellular aging to improve CAR-T therapy for solid tumors
Source: NIH RePORTER.
Company data compiled and maintained by Healthcare Discovery.
